Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine.

@article{Hellenbrand2013EpidemiologyOI,
  title={Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine.},
  author={Wiebke Hellenbrand and Johannes Elias and Ole Wichmann and Manuel Dehnert and Matthias Frosch and U. Vogel},
  journal={The Journal of infection},
  year={2013},
  volume={66 1},
  pages={
          48-56
        }
}
OBJECTIVES To analyse serogroup (Sg)- and finetype-specific invasive meningococcal disease burden (IMD) in Germany, 2002-2010, with emphasis on effects of vaccination with conjugate SgC vaccines targeting one-year old children since 2006, including individual-based catch-up to 17 years of age. METHODS Serogroup- and age-specific IMD incidence and trends were calculated using statutory surveillance data. The national reference laboratory performed genetic finetyping. Vaccination uptake data… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden , 2000 to 2010

  • S Thulin-Hedberg, B Törös, H Fredlund, P Olcén, P Mölling
  • Euro Surveill
  • 2011

Impfquoten bei den Schuleingangsuntersuchungen in Deutschland

  • Robert Koch-Institute
  • Epid Bull ;16:125-9
  • 2009

Invasive Meningokokken-Erkrankungen: Retrospektive Erhebung von Verdachtsmeldungen nach x 6 ABs. 1 IfSG Deutschland, 2001e2007

  • Robert Koch-Institute
  • Epid Bull ;(8):69-75
  • 2009

Similar Papers

Loading similar papers…